deltatrials
Completed PHASE1 INTERVENTIONAL 1-arm NCT04080024

A First-in-human Clinical Evaluation of SN132D in Patients With Breast and Pancreatic Cancer (SPAGOPIX-01)

A First-in-human Clinical Evaluation of the Novel Intravenous Contrast Agent SN132D in Patients With Breast and Pancreatic Cancer

Sponsor: Antaros Medical

Conditions Breast Cancer Pancreas Cancer
Interventions SN132D
Updated 13 times since 2019 Last updated: Dec 8, 2022 Started: Aug 23, 2019 Primary completion: Nov 30, 2022 Completion: Nov 30, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Breast Cancer and Pancreas Cancer and is currently completed. Antaros Medical leads this study, which shows 13 recorded versions since 2019 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~Jun 2020 · 7 months · monthly snapshot~Jun 2020 – ~Nov 2020 · 5 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Sep 2021 · 7 months · monthly snapshot~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Dec 2021 · 2 months · monthly snapshot~Dec 2021 – ~Jun 2022 · 6 months · monthly snapshot~Jun 2022 – ~Jan 2023 · 7 months · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE1

    Status: Recruiting → Completed

  4. Jun 2022 — Jan 2023 [monthly]

    Recruiting PHASE1

  5. Dec 2021 — Jun 2022 [monthly]

    Recruiting PHASE1

▶ Show 8 earlier versions

  1. Oct 2021 — Dec 2021 [monthly]

    Recruiting PHASE1

  2. Sep 2021 — Oct 2021 [monthly]

    Recruiting PHASE1

  3. Feb 2021 — Sep 2021 [monthly]

    Recruiting PHASE1

  4. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE1

  5. Nov 2020 — Jan 2021 [monthly]

    Recruiting PHASE1

  6. Jun 2020 — Nov 2020 [monthly]

    Recruiting PHASE1

  7. Nov 2019 — Jun 2020 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  8. Oct 2019 — Nov 2019 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Aug 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Antaros Medical
  • CTC Clinical Trial Consultants AB
  • Spago Nanomedical AB
Data source: Spago Nanomedical AB

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations